Internal Medicine & Nephrology is categorized under Internal Medicine Doctors in Edmond, OK and active since 2005.
Internal Medicine & Nephrology was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Mohammad Fazel Khalili at the company’s single location by writing to 105 South Bryant Avenue # 303, Edmond, Oklahoma OK 73034 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Internal Medicine & Nephrology |
Contact Person: | Mohammad Fazel Khalili |
Address: | 105 South Bryant Avenue # 303, Edmond, Oklahoma 73034 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Internal Medicine & Nephrology was started in 2005 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mohammad Fazel Khalili for inquiries that concern Internal Medicine & Nephrology by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Internal Medicine & Nephrology can be found at the coordinates as well as the street address 105 South Bryant Avenue # 303 in Edmond, Oklahoma 73034.
For its online presence, you may visit Internal Medicine & Nephrology’s website at and engage with its social media outlets through on Twitter and on Facebook.